Assignee
TRIPEP AB
SE·31 granted patents·4 pending applications·502 citations·filing 1995–2009
Top patents by PatentIndex Score
35 records- 0196US6469143B2Antigen/antibody specificity exchangerTRIPEP AB·Filed 2001·Granted Oct 22, 2002·44 cites·12 claims
- 0295US6417324B1Synthetic peptides that bind to the hepatitis B virus core and e antigensTRIPEP AB·Filed 2000·Granted Jul 9, 2002·33 cites·15 claims
- 0394US6660842B1Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogenTRIPEP AB·Filed 2000·Granted Dec 9, 2003·34 cites·34 claims
- 0494US6245895B1Antigen/antibody specificity exchangerTRIPEP AB·Filed 2000·Granted Jun 12, 2001·30 cites·3 claims
- 0593US7439347B2Hepatitis C virus non-structural NS3/4A fusion geneTRIPEP AB·Filed 2005·Granted Oct 21, 2008·12 cites·70 claims
- 0693US7226912B2Hepatitis C virus non-structural NS3/4A fusion geneTRIPEP AB·Filed 2006·Granted Jun 5, 2007·14 cites·84 claims
- 0793US7223743B2Hepatitis C virus codon optimized non-structural NS3/4A fusion geneTRIPEP AB·Filed 2006·Granted May 29, 2007·13 cites·84 claims
- 0893US6858590B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2001·Granted Feb 22, 2005·36 cites·14 claims
- 0992US6680059B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2002·Granted Jan 20, 2004·38 cites·55 claims
- 1090US7307066B2Hepatitis C virus codon optimized non-structural NS3/4A fusion geneTRIPEP AB·Filed 2005·Granted Dec 11, 2007·9 cites·73 claims
- 1190US6933366B2Specificity exchangers that redirect antibodies to bacterial adhesion receptorsTRIPEP AB·Filed 2003·Granted Aug 23, 2005·19 cites·19 claims
- 1289US7022830B2Hepatitis C virus codon optimized non-structural NS3/4A fusion geneTRIPEP AB·Filed 2002·Granted Apr 4, 2006·17 cites·11 claims
- 1388US6960569B2Hepatitis C virus non-structural NS3/4A fusion geneTRIPEP AB·Filed 2001·Granted Nov 1, 2005·28 cites·50 claims
- 1487US7332166B2Glycosylated specificity exchangersTRIPEP AB·Filed 2006·Granted Feb 19, 2008·6 cites·10 claims
- 1587US7318926B2Glycosylated specificity exchangersTRIPEP AB·Filed 2004·Granted Jan 15, 2008·10 cites·15 claims
- 1686US7638499B2Hepatitis C virus codon optimized non-structural NS3/4A fusion geneTRIPEP AB·Filed 2007·Granted Dec 29, 2009·4 cites·10 claims
- 1786US7241440B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2004·Granted Jul 10, 2007·10 cites·34 claims
- 1886US6040137AAntigen/antibody specification exchangerTRIPEP AB·Filed 1999·Granted Mar 21, 2000·35 cites·18 claims
- 1983US7019111B2Glycosylated ligand/receptor specificity exchangers specific for bacterial adhesion receptorsTRIPEP AB·Filed 2003·Granted Mar 28, 2006·6 cites·21 claims
- 2083US5869232AAntigen/antibody specificity exchangerTRIPEP AB·Filed 1995·Granted Feb 9, 1999·41 cites·17 claims
- 2182US7566812B2Transgenic mouse models of hepatitis C virus (HCV) and identification of HCV therapeuticsTRIPEP AB·Filed 2005·Granted Jul 28, 2009·4 cites·13 claims
- 2282US7534435B2Glycosylated specificity exchangersTRIPEP AB·Filed 2006·Granted May 19, 2009·4 cites·12 claims
- 2382US6455670B1Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereofTRIPEP AB·Filed 2001·Granted Sep 24, 2002·14 cites·21 claims
- 2481US7012129B2Antiviral composition comprising glycine amideTRIPEP AB·Filed 2003·Granted Mar 14, 2006·8 cites·19 claims
- 2577US7244715B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2006·Granted Jul 17, 2007·1 cites·18 claims
- 2675US6258932B1Peptides that block viral infectivity and methods of use thereofTRIPEP AB·Filed 1999·Granted Jul 10, 2001·31 cites·33 claims
- 2771US7335359B2Glycosylated specificity exchangersTRIPEP AB·Filed 2004·Granted Feb 26, 2008·1 cites·16 claims
- 2869US2009170953A1Indentification of compounds that inhibit replication of human immunodeficiency virusTRIPEP AB·Filed 2007·Application pending·0 cites
- 2967US7244422B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2006·Granted Jul 17, 2007·0 cites·12 claims
- 3065US2009305949A1Glycosylated specificity exchangerTRIPEP AB·Filed 2007·Application pending·0 cites
- 3163US7261883B2Vaccines containing ribavirin and methods of use thereofTRIPEP AB·Filed 2003·Granted Aug 28, 2007·0 cites·52 claims
- 3259US2009214593A1Immunogen platformTRIPEP AB·Filed 2009·Application pending·0 cites
- 3354US6537967B1Pentamer peptide amide, ALGPGNH2, which inhibits viral infectivity and methods of use thereofTRIPEP AB·Filed 2002·Granted Mar 25, 2003·0 cites·8 claims
- 3450US2009092631A1Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) responseTRIPEP AB·Filed 2008·Application pending·0 cites
- 3547US6593455B2Tripeptide amides that block viral infectivity and methods of use thereofTRIPEP AB·Filed 2001·Granted Jul 15, 2003·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when TRIPEP AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →